RNA Latest Press Releases

-- June 23, 2026 --

Atrium Therapeutics Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4) PRNewswire 4:05 PM

-- May 14, 2026 --

Atrium Therapeutics Reports First Quarter 2026 Financial Results PRNewswire 4:40 PM

-- April 23, 2026 --

Atrium Therapeutics Earns $15 Million Milestone Payment from Bristol Myers Squibb Under Global Cardiovascular Collaboration PRNewswire 8:00 AM

-- April 20, 2026 --

Atrium Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) PRNewswire 10:47 PM

-- February 27, 2026 --

Atrium Therapeutics Launches with Approximately $270 Million to Advance Novel RNA Medicines for Rare Genetic Cardiomyopathies PRNewswire 9:20 AM

-- February 26, 2026 --

Avidity Biosciences Announces Multiple Upcoming Presentations at 2026 Muscular Dystrophy Association (MDA) Clinical & Scientific Conference PRNewswire 4:03 PM

-- February 23, 2026 --

Avidity Biosciences Announces Intention to Adjourn and Reconvene Special Meeting of Stockholders PRNewswire 8:00 AM

-- February 18, 2026 --

The New England Journal of Medicine Publishes Results from Phase 1/2 MARINA Trial of Delpacibart Etedesiran (del-desiran) for Treatment of Myotonic Dystrophy Type 1 PRNewswire 5:00 PM

Market Data Delayed 15 Minutes

Questions? Feedback?Olark live chat software